On Dec 03, 2025, HQY reported earnings of 1.01 USD per share (EPS) for Q3 26, beating the estimate of 0.93 USD, resulting in a 7.72% surprise. Revenue reached 322.16 million, compared to an expected 324.24 million, with a -0.64% difference. The market reacted with a -3.01% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 15 analysts forecast an EPS of 0.90 USD, with revenue projected to reach 335.98 million USD, implying an decrease of -10.89% EPS, and increase of 4.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
FAQ
What were HealthEquity, Inc's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, HealthEquity, Inc reported EPS of $1.01, beating estimates by 7.72%, and revenue of $322.16M, -0.64% below expectations.
How did the market react to HealthEquity, Inc's Q3 2026 earnings?
The stock price moved down -3.01%, changed from $98.64 before the earnings release to $95.67 the day after.
When is HealthEquity, Inc expected to report next?
The next earning report is scheduled for Mar 16, 2026.
What are the forecasts for HealthEquity, Inc's next earnings report?
Based on 15
analysts, HealthEquity, Inc is expected to report EPS of $0.90 and revenue of $335.98M for Q4 2026.